Bilateral Oophorectomy versus Ovarian Conservation: Effects on Long-term Women's Health

Journal of Minimally Invasive Gynecology

Volumn 17, Issue 2, 2010, Pages 161-166

  Parker, William H ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADNEXA DISEASE; ANXIETY; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RISK; COGNITIVE DEFECT; CORONARY ARTERY DISEASE; DEMENTIA; DEPRESSION; ESTROGEN DEFICIENCY; GYNECOLOGIC SURGERY; HIP FRACTURE; HUMAN; HYSTERECTOMY; INTERMETHOD COMPARISON; MOOD CHANGE; OSTEOPOROSIS; OVARIAN CONSERVATION; OVARIECTOMY; OVARY CANCER; PARKINSONISM; POSTMENOPAUSE; PREMENOPAUSE; QUALITY OF LIFE; REOPERATION; SEXUALITY; STROKE;

ADULT; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; OVARIAN DISEASES; OVARIECTOMY; RISK ASSESSMENT;

EID: 77649251518     PISSN: 15534650     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmig.2009.12.016     Document Type: Article

References (59)

1. Armstrong K., Schwartz J., Randall T., Rubin S., and Weber B. Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis. J Clin Oncol 22 (2004) 1045-1054
2. Healthcare Cost and Utilization Project (HCUP), 1988-2001: A Federal-State-Industry Partnership in Health Data. July 2003. Agency for Healthcare Research and Quality, Rockville, MD. http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5105a1.htm
3. Progetto Menopausa Italia Study Group 1. Determinants of hysterectomy and oophorectomy in women attending menopause clinics in Italy. Maturitas 36 (2000) 19-25
4. Judd H., Judd G., Lucas W., and Yen S. Endocrine function of the postmentopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinl Metab 39 (1974) 1020-1024
5. Fogle R., Stanczyk F., Zhang X., and Paulson R. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab 92 (2007) 3040-3043
6. Meldrum D., Davidson B., Tataryn I., and Judd H. Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol 57 (1981) 624-628
7. Colditz G., Willett W., Stampfer M., Rosner B., Speizer F., and Hennekens C. Menopause and the risk of coronary heart disease in women. N Engl J Med 316 (1987) 1105-1110
8. Ohta H., Makitab K., Komukaib S., and Nozawab S. Bone resorption versus estrogen loss following oophorectomy and menopause. Maturitas 43 (2002) 27-33
9. Rocca W., Bower J., Maraganore D., Ahlskog J., Grossardt B., de Andrade M., and Melton L. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 69 (2007) 1074-1083
10. Rocca W., Bower J.H., Maraganore D., Ahlskog J., Grossardt B., de Andrade M., and Melton L. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 70 (2008) 200-209
11. Rocca W., Grossardt B., Geda Y., Gostout B., Bower J., Maraganore D., de Andrade M., and Melton J. Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause 15 (2008) 1050-1059
12. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
13. Hartge P., Whittemore A.S., Itnyre J., McGowan L., and Cramer D. Rates and risks of ovarian cancer in subgroups of white women in the United States: The Collaborative Ovarian Cancer Group. Obstet Gynecol 84 (1994) 760-764
14. Naylor A.C. Hysterectomy-analysis of 2901 personally performed procedures. S Afr Med J 65 (1984) 242-245
15. Christ J.E., and Lotze E.C. The residual ovary syndrome. Obstet Gynecol 46 (1975) 551-556
16. Parker W.H., Broder M.S., Chang E., et al. Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses' Health Study. Obstet Gynecol 113 (2009) 1027-1037
17. Kreiger N., Sloan M., Cotterchio M., and Kirsh V. The risk of breast cancer following reproductive surgery. Eur J Cancer 35 (1999) 97-101
18. Schairer C., Persson I., Falkeborn M., Naessen T., Troisi R., and Brinton L.A. Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 70 (1997) 150-154
19. SEER Cancer Statistics Review 1975-2006, National Cancer Institute, http://seer.cancer.gov/csr/1975_2006/results_merged/sect_04_breast.pdf accessed 9/4/09.
20. Koushik A, Parent M, Siemiatycki J. Characteristics of menstruation and pregnancy and the risk of lung cancer in women. Int J Cancer
21. Dekel A. Eur J Obstet Gynecol Reprod Biol 68 (1996) 159-164
22. Bailey C.L., Ueland F.R., Land G.L., DePriest P.D., Gallion H.H., Kryscio R.J., and van Nagell Jr. J.R. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol 69 (1998) 3-7
23. Parker W., Broder M., Liu Z., Shoupe D., Farquhar C., and Berek J. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 106 (2005) 219-226
24. Rocca W., Grossardt B., de Andrade M., Malkasian G., and Melton J. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 7 (2006) 821-828
25. Rivera C., Grossardt B., Rhodes D., and Rocca W. Increased Mortality for Neurological and Mental Diseases following Early Bilateral Oophorectomy. Neuroepidemiology 33 (2009) 32-40
26. Van der Schouw Y., van der Graa Y., Steyerberg E., Eijkemans M., and Banga J. Age at menopause as a risk factor for cardiovascular mortality. Lancet 347 (1996) 714-718
27. Løkkegaarda E., Jovanovicb Z., Heitmannc B., Keidingb N., Ottesend B., and Pedersend A. The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy. Maturitas 53 (2006) 226-233
28. de Kleijn M.J.J., van der Schouw Y.T., Verbeek A.L.M., Peeters P.H.M., Banga J.-D., and van der Graaf Y. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal American women. J Epidemiology 155 (2002) 339-345
29. Falkeborn M., Schairer C., Naessen T., and Persson I. Risk of myocardial infarction after oophorectomy and hysterectomy. J Clin Epidemiol 53 (2000) 832-837
30. Jacoby V.L., Grady D., and Sawaya G.F. Oophorectomy as a risk factor for coronary heart disease. Am J Obstet Gynecol 200 (2009) 140
31. Kreiger N., Kelsey J., Holford T.R., and O'Connor T. An epidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol 116 (1982) 141-148
32. Raisz R.K., Wilta B., Artis A., Bowen A., Schwartz S., Trahiotis M., Shoukri K., and Smith J. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 81 (1996) 37-43
33. Ohta H., Makitab K., Komukaib S., and Nozawab S. Bone resorption versus estrogen loss following oophorectomy and menopause. Maturitas 43 (2002) 27-33
34. Melton J., Khosla S., Malkasian G.D., Achenbach S.J., Oberg A.L., and Riggs B.L. Fracture risk after bilateral oophorectomy in elderly women. J Bone Miner Res 18 (2003) 900-905
35. Kritz-Silverstein D., von Mühlen D., and Barrett-Connor E. Hysterectomy and oophorectomy are unrelated to bone loss in older women. Maturitas 47 (2004) 61-69
36. Antoniucci D.M., Sellmeyer D.E., Cauley J.A., Ensrud K.E., Schneider J.L., Vesco K.K., Cummings S.R., and Melton III L.J. Study of Osteoporotic Fractures Research Group. Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women. J Bone Miner Res 20 (2005) 741-747
37. Keene G., Parker M., and Pryor G. Mortality and morbidity after hip fractures. BMJ 13 (1993) 1248-1250
38. Vestergaard P., Rejnmark L., and Mosekilde L. Loss of life years after a hip fracture: Effects of age and sex. Acta Orthopaedica 80 (2009) 525-530
39. Benedetti M.D., Maraganore D.M., Bower J.H., et al. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov Disord 16 (2001) 830-837
40. Ragonese P., D'Amelio M., Salemi G., et al. Risk of Parkinson disease in women: effect of reproductive characteristics. Neurology 62 (2004) 2010-2014
41. Ascherio A., Chen H., Schwarzschild M., Zhang S., Colditz G., and Speizer F. Caffeine, postmenopausal estrogen, and risk of Parkinson's disease. Neurology 60 (2003) 790-795
42. Nappi R., Sinforiani E., Mauri M., Bono G., Polatti F., and Nappi G. Memory functioning at menopause: impact of age in ovariectomized women. Gynecol Obstet Invest 47 (1999) 29-36
43. Farrag A., Khedr E., Abdel-Aleem H., and Rageh T. Effect of surgical menopause on cognitive functions. Demet Geriatr Cogn Disord 13 (2002) 193-198
44. Kritz-Silverstein D., and Barrett-Connor E. Hysterectomy, oophorectomy, and cognitive function in older women. J Am Geriatr Soc 50 (2002) 55-61
45. Nathorst-Boos J., von Schoultz B., and Carlstrom K. Elective ovarian removal and estrogen replacement therapy-effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 14 (1993) 283-293
46. Nieman L. Management of surgically hypogonadal patients unable to take sex hormone replacement therapy. Endocrinol Metab Clin North Am 32 (2003) 325-236
47. Hansen K. Female reproductive biology. In: O'Leary P., Tabuenca A., and Capote L.R. (Eds). The physiologic basis of surgery (2007), Lippincott Williams and Wilkins, Philadelphia 314-315
48. Shifren J. Androgen deficiency in the oophorectomized woman. Fertil Steril 77 Suppl 4 (2002) s60-s62
49. Sherwin B., and Gelfan M. the role of androgens in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 49 (1978) 397-409
50. Gallicchio L., Whiteman M.K., Tomic D., Miller K.P., Langenberg P., and Flaws J.A. Type of menopause, patterns of hormone therapy use, and hot flashes. Fertil Steril 85 (May, 2006) 1432-1440
51. Farrag A., Khedr E., Abdel-Aleem H., and Rageh T. Effect of surgical menopause on cognitive functions. Demet Geriatr Cogn Disord 13 (2002) 193-198
52. Sherwin B. Surgical menopause, estrogen and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13 (1988) 345-357
53. Bachmann G.A., and Nevadunsky N.S. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 61 (2000) 3090-3096
54. Lieblum S., Bachmann G., Kemmann E., Colburn D., and Swartzman L. Vaginal atrophy in the postmenopausal woman. The importance of sexual activity and hormones. JAMA 249 (1983) 2195-2198
55. Schifren J., Braustein G., Simon J., et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343 (2000) 682-688
56. Elit l., Esplen M., Butler K., and Narod S. Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. Familial Cancer 1 (2001) 149-156
57. Sherwin B.B., and Gelfan M.M. the role of androgens in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 49 (1978) 397-409
58. Teplin V., Vittinghoff E., Lin F., Learman L., Richter H., and Kuppermann M. Oophorectomy in premenopausal women: health-related quality of life and sexual functioning. Obstet Gynecol 109 (2007) 347-354
59. Wegienka G., Havstad S., and Kelsey J. Menopausal hormone therapy in a health maintenance organization before and after Women's Health Initiative hormone trials termination. J Women's Health 15 (2006) 369-378